Investigator profile: Richard J. O'Reilly interviewed by Glaser VP.
O'Reilly
R J
RJ
D000818:Animals; D016026:Bone Marrow Transplantation / Q000009:adverse effects / Q000639:trends; D017690:Cell Transplantation; D002648:Child; D002678:Chimera; D016332:Fetal Tissue Transplantation; D005544:Forecasting; D015316:Genetic Therapy; D006086:Graft vs Host Disease / Q000209:etiology / Q000517:prevention & control; D020544:Graft vs Leukemia Effect; D006801:Humans; D007153:Immunologic Deficiency Syndromes / Q000628:therapy*; D007694:Killer Cells, Natural / Q000637:transplantation; D007938:Leukemia / Q000628:therapy; D016031:Liver Transplantation; D008212:Lymphocyte Depletion; D051379:Mice; D016511:Severe Combined Immunodeficiency / Q000628:therapy; D016176:T-Lymphocyte Subsets / Q000276:immunology; D013950:Thymus Gland / Q000166:cytology / Q000196:embryology / Q000637:transplantation; D014019:Tissue Donors; D014184:Transplantation, Homologous / Q000009:adverse effects